Ontology highlight
ABSTRACT:
SUBMITTER: Yoon HA
PROVIDER: S-EPMC7724683 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
Yoon Hyun Ah HA Bartash Rachel R Gendlina Inessa I Rivera Johanna J Nakouzi Antonio A Bortz Robert H RH Wirchnianski Ariel S AS Paroder Monika M Fehn Karen K Serrano-Rahman Leana L Babb Rachelle R Sarwar Uzma N UN Haslwanter Denise D Laudermilch Ethan E Florez Catalina C Dieterle M Eugenia ME Jangra Rohit K RK Fels J Maximilian JM Tong Karen K Mariano Margarette C MC Vergnolle Olivia O Georgiev George I GI Herrera Natalia G NG Malonis Ryan J RJ Quiroz Jose A JA Morano Nicholas C NC Krause Gregory J GJ Sweeney Joseph M JM Cowman Kelsie K Allen Stephanie S Annam Jayabhargav J Applebaum Ariella A Barboto Daniel D Khokhar Ahmed A Lally Brianna J BJ Lee Audrey A Lee Max M Malaviya Avinash A Sample Reise R Yang Xiuyi A XA Li Yang Y Ruiz Rafael R Thota Raja R Barnhill Jason J Goldstein Doctor Y DY Uehlinger Joan J Garforth Scott J SJ Almo Steven C SC Lai Jonathan R JR Gil Morayma Reyes MR Fox Amy S AS Chandran Kartik K Wang Tao T Daily Johanna P JP Pirofski Liise-Anne LA
medRxiv : the preprint server for health sciences 20201204
Convalescent plasma with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) antibodies (CCP) may hold promise as treatment for Coronavirus Disease 2019 (COVID-19). We compared the mortality and clinical outcome of patients with COVID-19 who received 200mL of CCP with a Spike protein IgG titer ≥1:2,430 (median 1:47,385) within 72 hours of admission to propensity score-matched controls cared for at a medical center in the Bronx, between April 13 to May 4, 2020. Matching criteria for contr ...[more]